Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

Abstract Objectives The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammat...

Full description

Bibliographic Details
Main Authors: Stefano Barco, Roland Bingisser, Giuseppe Colucci, André Frenk, Bernhard Gerber, Ulrike Held, Francois Mach, Lucia Mazzolai, Marc Righini, Thomas Rosemann, Tim Sebastian, Rebecca Spescha, Stefan Stortecky, Stephan Windecker, Nils Kucher
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Trials
Subjects:
COVID-19
Randomised controlled trial
protocol
enoxaparin
anticoagulation
elderly
Online Access:http://link.springer.com/article/10.1186/s13063-020-04678-4

Internet

http://link.springer.com/article/10.1186/s13063-020-04678-4

Similar Items